Urokinase-Type Plasminogen Activator Concept

Vocabulary Service

MeSH

Overview

subject area of

Antithrombotic Drugs Journal Articles
Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke Journal Articles
Effect of ascorbate on fibrinolytic factors in septic mouse skeletal muscle Journal Articles
Evaluation of urokinase plasminogen activator in urine from individuals with Quebec platelet disorder Journal Articles
Fibrin Clot Lysis by Thrombolytic Agents Is Impaired in Newborns due to a Low Plasminogen Concentration Journal Articles
Growth factors, tissue and urokinase-type plasminogen activators in venous ulcers. Journal Articles
In acute ischemic stroke, early intraarterial treatment plus usual care improved functional independence Journal Articles
Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation Journal Articles
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Journal Articles
Inhibition of Plasminogen Activator Inhibitor-1 Restores Skeletal Muscle Regeneration in Untreated Type 1 Diabetic Mice Journal Articles
Intra-arterial Prourokinase for Acute Ischemic Stroke Journal Articles
Intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder Journal Articles
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials Journal Articles
Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysis Journal Articles
Lower levels of PAI-2 may contribute to impaired healing in venous ulcers - a preliminary study. Journal Articles
Mechanism of Action of Plasminogen Activators Journal Articles
Observations in anticoagulant and thrombolytic therapy in pulmonary embolism Journal Articles
Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene Journal Articles
Plasma Urokinase Antigen and Plasminogen Activator Inhibitor-1 Antigen Levels Predict Angiographic Coronary Restenosis Journal Articles
Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator Journal Articles
Propagating factor IX-producing hepatocytes for haemophilia B therapy Journal Articles
Quebec Platelet Disorder: Update on Pathogenesis, Diagnosis, and Treatment Journal Articles
Quebec platelet disorder Journal Articles
Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes Journal Articles
Quebec platelet disorder: features, pathogenesis and treatment Journal Articles
Regulation of plasminogen activator inhibitor‐1 secretion by urokinase and tissue plasminogen activator in rat epithelioid‐type smooth muscle cells Journal Articles
Results of a Prospective Randomized Trial Evaluating Surgery Versus Thrombolysis for Ischemia of the Lower Extremity The STILE Trial Journal Articles
Re‐engineering the Immune Response to Metastatic Cancer: Antibody‐Recruiting Small Molecules Targeting the Urokinase Receptor Journal Articles
Sleep Hypoxemia at High Altitude Journal Articles
Stability and sterility of recombinant tissue plasminogen activator at −30°C Journal Articles
Studies on the medical treatment of deep vein thrombosis. Journal Articles
Superior mesenteric vein thrombosis after the Whipple procedure: an aggressive, combined treatment approach. Journal Articles
THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION. Journal Articles
TREATMENT OF PULMONARY EMBOLISM Journal Articles
The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes Journal Articles
Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review. Journal Articles
Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Journal Articles
Thrombolytic therapy for the treatment of acute pulmonary embolism. Journal Articles
Tissue and urokinase plasminogen activators in the environs of venous and ischaemic leg ulcers Journal Articles
Treatment of venous thromboembolic disease. Journal Articles
Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin. Journal Articles
Use of thrombolytic agents to treat neonatal thrombosis in clinical practice Journal Articles